News

CHICAGO, IL – October 27, 2023 – Sheridan Capital Partners (“Sheridan”) announced today the formation of Ascend Plastic Surgery Partners (“Ascend” or the “Company”), a plastic surgery physician practice management company. Today, Ascend represents the combination of five plastic surgery practices and two standalone MedSpas. Sheridan invested alongside Ascend’s surgeons and management, who have retained a meaningful ownership stake in the business.

Ascend is headquartered in Atlanta, Georgia, and currently provides care in Alabama, New Mexico, South Carolina, and Utah. The Company offers a full range of plastic surgery and med spa services to its patients. Dr. William Hedden, a board-certified and tenured surgeon in the specialty, will assume the position of Chief Medical Officer of the newly formed entity. Sheridan partnered with Dr. Hedden, along with a team of accomplished physicians, to establish Ascend Plastic Surgery Partners. Ascend will continue to bring together and support plastic surgeons who dedicate themselves to the mission of providing high quality care and service.

“This partnership represents an exciting opportunity to redefine excellence in plastic surgery. By uniting our practices and expertise, we aim to deliver unparalleled patient experiences and outcomes,” commented Dr. Hedden, Chief Medical Officer. "We chose to partner with Sheridan given their extensive experience building physician-centric practice management businesses, their dedication to a plastic surgery-focused platform and their respect for and alignment with our clinical goals.”

“Ascend is an early mover in the highly fragmented cosmetic plastic surgery market and immediately becomes one of the few platforms of scale dedicated to the specialty,” said Nicholas Rowland, a Partner at Sheridan Capital Partners. “We are honored to be partnered with such strong clinical leaders and remain aligned in our collective vision to build a differentiated, high-growth platform that continues to attract talented plastic surgeons and deliver an elevated patient experience.”

“We believe that Ascend has the potential to advance the industry standard through its commitment to innovation, patient care, and clinical excellence," adds Sheridan Principal Chris McCrory.

The transaction was led by Jonathan Lewis, Nicholas Rowland, Christopher McCrory, Stephen Lestyan, and Munib Ansari at Sheridan Capital Partners. McDermott Will & Emery LLP served as legal counsel to Sheridan Capital Partners. Financial terms of the transaction were not disclosed.